BlackRock Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 13,003,600 shares of the company's stock, valued at approximately $5,069,974,000. BlackRock Inc. owned approximately 6.01% of HCA Healthcare at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in HCA. Palisade Asset Management LLC acquired a new position in shares of HCA Healthcare during the third quarter valued at about $26,000. Clearstead Trust LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $29,000. Ares Financial Consulting LLC purchased a new stake in HCA Healthcare in the 4th quarter worth $31,000. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $33,000. Finally, JPL Wealth Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter worth approximately $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Price Performance
NYSE HCA opened at $412.27 on Wednesday. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The stock has a market capitalization of $89.26 billion, a P/E ratio of 13.80, a PEG ratio of 1.40 and a beta of 1.10. The firm's 50-day moving average is $395.07 and its two-hundred day moving average is $445.35.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the previous year, the company earned $6.84 earnings per share. The firm's quarterly revenue was up 8.7% compared to the same quarter last year. As a group, analysts anticipate that HCA Healthcare, Inc. will post 29.47 EPS for the current year.
HCA Healthcare Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare's payout ratio is 10.45%.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Sanford C. Bernstein reaffirmed a "market perform" rating on shares of HCA Healthcare in a report on Wednesday, July 15th. KeyCorp cut their price objective on shares of HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating for the company in a report on Monday, July 27th. Truist Financial reduced their price objective on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Barclays dropped their target price on HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating for the company in a report on Monday, July 27th. Finally, Robert W. Baird dropped their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating for the company in a report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and an average price target of $465.59.
Get Our Latest Analysis on HCA Healthcare
About HCA Healthcare
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.